Plain-English translation of NCT06551129 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study that follows people who are taking , a medication designed to help the heart muscle work more efficiently in patients with obstructive hypertrophic cardiomyopathy. Instead of testing the medication itself, researchers want to learn how people actually feel and function while taking it in their everyday lives. You'll share your health updates through surveys over time.
Doctors have a new treatment option, but they want to understand how it affects people's quality of life, energy levels, and daily activities in real-world conditions—not just in a controlled research setting.
You likely qualify if…
You likely don't qualify if…
You'll complete online surveys at different time points to describe how you're feeling, your energy levels, your ability to exercise, and how the medication is affecting your daily life. The study is designed to be straightforward and fit into your normal routine—you're not being asked to make extra doctor visits or undergo special tests. Researchers will track your experiences over time to understand how the medication works in real life.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
United States
Sponsor
Bristol-Myers Squibb
Enrollment target
~118 participants
Started
May 2024
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
BMS Study Connect Contact Center www.BMSStudyConnect.com
Bristol-Myers Squibb
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.